Status:
UNKNOWN
Glaucoma Screening With Artificial Intelligence
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Orbis
Conditions:
Glaucoma
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This randomized clinical trial aims to compare the diagnostic performance of two AI-enabled screening strategies - ROTA (RNFL optical texture analysis) assessment versus optic disc photography - in de...
Detailed Description
Glaucoma is the leading cause of irreversible blindness affecting 76 million patients worldwide in 2020. Characterized by progressive degeneration of the optic nerve, early detection of disease deteri...
Eligibility Criteria
Inclusion
- Individuals aged 50 years or above
Exclusion
- Physically incapacitated
- Not able to cooperate for clinical examination or optical coherence tomography (OCT) investigation will be excluded
Key Trial Info
Start Date :
August 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 25 2025
Estimated Enrollment :
3175 Patients enrolled
Trial Details
Trial ID
NCT06012058
Start Date
August 26 2023
End Date
February 25 2025
Last Update
September 21 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Southern District Wah Kwai Community Centre
Aberdeen, Hong Kong
2
Kwun Tong District Health Centre
Kwun Tong, Hong Kong